ONCOVIR
Live / Registered — Registered and renewed (as of 02 Feb 2016)
What this means for you
Registered since 10 Oct 2006. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Oct 2016).
Record
- Serial number
- 78215231
- Registration number
- 3154691
- Mark type
- Word mark
- Filed
- 14 Feb 2003
- Published for opposition
- 12 Oct 2004
- Registered
- 10 Oct 2006
- Next maintenance due
- 10 Oct 2016
- Attorney of record
- KATHRYN JENNISON SHULTZ
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for treatment of viral and oncological disease
Owner
- ONCOVIR, INC., WASHINGTON, DC, US
- ONCOVIR, INC., WASHINGTON, DC, US
- ONCOVIR, INC., WASHINGTON, DC, US
- Ribopharm, Inc., Washington, DC, US
Prosecution history
- 02 Feb 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
- 02 Feb 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 02 Feb 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 02 Feb 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Nov 2015 — TEAS SECTION 8 & 9 RECEIVED
- 16 Feb 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
- 16 Feb 2012 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 16 Feb 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jan 2012 — TEAS SECTION 8 & 15 RECEIVED
- 10 Oct 2006 — REGISTERED-PRINCIPAL REGISTER
- 26 Aug 2006 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 18 Aug 2006 — ASSIGNED TO LIE
- 15 Aug 2006 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Aug 2006 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jun 2006 — USE AMENDMENT FILED